More on CAMP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+59.7% Growth)
- Ratings (7.1 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/13/26)
- M&A (6/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CAMP4 Therapeutics (NQ:CAMP)
Delayed: 3.11 --0 (-0%)
Prev. Close $3.11  
Open$3.11 
52 Wk High$21.34 
52 Wk Low$12.13 
Day High$3.11 
Day Low$3.11 
P/E 2.34  
EPS$1.33 
Volume52 

Friends, Peers and Foes (?): A68, STH, LTRX, RFIL, SQNS (more...)

Jul 17, 2026 04:05 PM CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 1, 2026 07:00 AM X4 Pharmaceuticals adds Kelly Gold to its board of directors
Jul 1, 2026 07:00 AM X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors
Jun 19, 2026 04:05 PM CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 16, 2026 12:37 AM JPMorgan Upgrades CAMP4 Therapeutics Corp (CAMP) to Overweight
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Schwab Andrew J.
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Young Richard A
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: WILLIAMS DOUGLAS E
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Holtzman Steven H
Jun 12, 2026 04:16 PM Form 4 Camp4 Therapeutics Corp For: Jun 10 Filed by: Stewart Murray
View All Articles

Entities mentioned with CAMP

View All Entities